{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:58:27Z","timestamp":1790798307819,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1212\/wnl.46.5.1391","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:19:55Z","timestamp":1336915195000},"page":"1391-1391","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":89,"title":["Calcium channel blockers and transmitter release at the normal human neurornuscular junction"],"prefix":"10.1212","volume":"46","author":[{"given":"Dario A.","family":"Protti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Reisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas Angelillo","family":"Mackinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo D.","family":"Uchitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"Katz B. The release of neurotransmitter substances. Liverpool: University Press 1969."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb36476.x"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Carbone E Lux HD. A low voltage-activated calcium conductance in embryonic chick sensory neurons. Nature 1984;310: 501\u2013502.","DOI":"10.1038\/310501a0"},{"key":"e_1_3_1_5_2","first-page":"8","volume":"18","year":"1995","unstructured":"Dunlap K, Luebke JL, Turner TJ. Exocitotic Cat2+ channels in mammalian central neurons. Trends Neurosci 1995;18:89\u201398.","journal-title":"Trends Neurosci"},{"key":"e_1_3_1_6_2","first-page":"5","volume":"311","year":"1984","unstructured":"Hess P, Lansman JB, Tsien RW. Different modes of Ca2+ channel gating behaviour favoured by dihidropyridine Ca2+ agonists and antagonists. Nature 1984;311:538\u2013544.","journal-title":"Nature"},{"key":"e_1_3_1_7_2","first-page":"4","volume":"11","year":"1988","unstructured":"Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 1988;11:431\u2013438.","journal-title":"Trends Neurosci"},{"key":"e_1_3_1_8_2","first-page":"4","volume":"84","year":"1987","unstructured":"McCleskey EW, Fox AP, Feldman DH, et al. \u03a9-Conotoxin direct and persistent blockade of specific types of calcium channels in neurons but not muscles. Proc Natl Acad Sci USA 1987;84:4327\u20134331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.1.1"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Mintz I Adams M Bean B. P-type calcium channels in rat central and peripheral neurons. Neuron 1992-b;9:85\u201395.","DOI":"10.1016\/0896-6273(92)90223-Z"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Mintz IM Venema VJ Swiderek KM Lee TD Bean BP Adams ME. P-type calcium channels blocked by the spider toxin \u03a9-Aga-IVA. Nature 1992-a;335:827\u2013829.","DOI":"10.1038\/355827a0"},{"key":"e_1_3_1_12_2","first-page":"1","volume":"19","year":"1993","unstructured":"Randall AD, Wendland B, Schweizer F, Miljanich G, Adams ME, Tsien RW. Five pharmacologically distinct high voltage-activated Ca2+ channels in cerebellar granule cells [abstract]. Soc Neurosci Abstracts 1993;19:1478.","journal-title":"Soc Neurosci Abstracts"},{"key":"e_1_3_1_13_2","first-page":"3","volume":"89","year":"1992","unstructured":"Uchitel OD, Protti DA, Sanchez VN, Cherksey BD, Sugimori M, Llinas RR. P-type voltage dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 1992;89:3330\u20133333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_14_2","first-page":"3","volume":"5","year":"1993","unstructured":"Protti DA, Uchitel OD. Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin \u03a9-Aga-IVA. Neuro-report 1993;5:333\u2013336.","journal-title":"Neuro-report"},{"key":"e_1_3_1_15_2","first-page":"1","volume":"20","year":"1994","unstructured":"Protti DA, Uchitel OD. Calcium influx through P-type channels activates closely associated calcium dependent potassium channels at the mouse motor nerve terminals [abstract]. SOC Neurosci Abstracts 1994;20:1719.","journal-title":"SOC Neurosci Abstracts"},{"key":"e_1_3_1_16_2","first-page":"6","volume":"2","year":"1989","unstructured":"Sher E, Gotti C, Canal N, et al. Specificity of calcium channel autoantibodies in Lambed-Eaton myasthenic syndrome. Lancet 1989;2:640\u2013643.","journal-title":"Lancet"},{"key":"e_1_3_1_17_2","first-page":"1","volume":"37","year":"1995","unstructured":"Mosier DR, Baldelli P, Delbono O, et al. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line. Ann Neurol 1995;37:102\u2013109.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_18_2","first-page":"7","volume":"85","year":"1988","unstructured":"Uchitel OD, Appel SH, Crawford F, Sczcupak L. Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor nerve terminals. Proc Natl Acad Sci USA 1988;85:7371\u20137374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_19_2","first-page":"2","volume":"141","year":"1987","unstructured":"Sano K, Enomoto K, Maeno T. Effects of synthetic \u03a9-conotoxin, a new type Ca2+ antagonist, on frog and mouse neuro-muscular transmission. Eur J Pharmacol 1987;141:235\u2013241.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880150103"},{"key":"e_1_3_1_21_2","first-page":"5","volume":"9","year":"1986","unstructured":"Krendel DA, Hopkins LC. Adverse effect of verapamil in a patient with the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1986;9:519\u2013522.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_22_2","first-page":"2","volume":"42","year":"1992","unstructured":"Uchitel OD, Scornik FS, Protti DA, Fumberg CG, Alvarez VA, Appel SH. Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis (ALS) immunoglobulins. Neurology 1992;42:2175\u20132180.","journal-title":"Neurology"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.1"},{"key":"e_1_3_1_24_2","first-page":"C","volume":"260","year":"1991","unstructured":"Delbono O, Garcia J, Appel SH, Stefani E. Am J Physiol 1991;260:C1347\u2013C1351.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_25_2","unstructured":"Protti DA Reisin R Angelillo Mackinley T Uchitel OD. Transmitter release at the human neuromuscular junction is mediated by P-type calcium channels [abstract]. Neurology 1993;43(suppl 4):A166."},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Katz E Ferro PA Cherksey BD Sugimori M Llinas RR Uchitel OD. Effects of Ca 2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction. J Phvsiol (Lond) 1995:48613):695\u2013706.","DOI":"10.1113\/jphysiol.1995.sp020845"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Ousley AH Froehner SC. An anti-peptide antibody specific for the class A calcium channel \u03b21 subunit labels mammalian neuromuscular junction. Proc Natl Acad Sci USA 1994;91: 12263\u201312267.","DOI":"10.1073\/pnas.91.25.12263"},{"key":"e_1_3_1_28_2","first-page":"8","volume":"266","year":"1994","unstructured":"Wheeler DB, Tsien RW, Randall A. Identification of calcium channels that control neurosecretion. Science 1994;266:830\u2013831.","journal-title":"Science"},{"key":"e_1_3_1_29_2","first-page":"8","volume":"266","year":"1994","unstructured":"Dunlap K, Luebke JI, Turner TI. Identification of calcium channels that control neurosecretion. Science 1994;266:828\u2013830.","journal-title":"Science"},{"key":"e_1_3_1_30_2","first-page":"6","volume":"42","year":"1984","unstructured":"Lang B, Molenaar PC, Newsom-Davis J, Vincent A. Passive transfer of LEMS in mice: decreased rate of resting and evoked release of acetylcholine from skeletal muscle. J Neurochem 1984;42:658\u2013662.","journal-title":"J Neurochem"},{"key":"e_1_3_1_31_2","first-page":"3","volume":"89","year":"1992","unstructured":"Leveque C, Hoshino T, Pascale D, et al. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc Natl Acad Sci USA 1992;89:3625\u20133629.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(90)90696-7"},{"key":"e_1_3_1_33_2","first-page":"2","volume":"341","year":"1990","unstructured":"Wessler I, Dooley DJ, Werhand J, Schlemmer F. Differential effects of calcium channel antagonists (omega-conotoxin-GVIA, nifedipine, verapamil) on the electrically evoked re-lease of [3H]acetylcholine from myenteric plexus, phrenic nerve and neocortex of rats. Naunyn Schmiedebergs Arch Pharmacol 1990;341:288\u2013294.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"e_1_3_1_34_2","first-page":"6","volume":"251","year":"1989","unstructured":"Atchinson WD. Dihidropiridine-sensitive and insensitive components of acetylcholine release from rat motor nerve terminals. J Pharmacol Exp Ther 1989;251:672\u2013678.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_35_2","first-page":"2","volume":"30","year":"1989","unstructured":"Pancrazio JJ, Viglione MP, Kim YI. Effect of BayK 8644 on spontaneous and evoked transmitter release at the mouse neuromuscular junction. Neuroscience 1989;30:215\u2013221.","journal-title":"Neuroscience"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.5.1391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:08:19Z","timestamp":1711548499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.5.1391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["10.1212\/WNL.46.5.1391"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.5.1391","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}